Open AccessPost‐streptococcal uveitis
Author(s) -
Gallagher Micheal J.,
Muqit Mahiul M. K.,
Jones David,
Gavin Mike
Publication year - 2006
Publication title -
acta ophthalmologica scandinavica
Language(s) - English
Resource type - Journals
eISSN - 1600-0420
pISSN - 1395-3907
DOI - 10.1111/j.1600-0420.2005.00594.x
Subject(s) - medicine , uveitis , intermediate uveitis , dermatology , anterior uveitis , antibiotics , epidemiology , ophthalmology , pediatrics , surgery , biology , microbiology and biotechnology
. Purpose: To describe the clinical features of post‐streptococcal uveitis (PSU) and examine management strategies in the treatment of this under‐recognized condition.Methods: Patients were identified from the world literature using the Pubmed search engine. We examined two new cases of post‐streptococcal intermediate uveitis. The epidemiology, immune mechanisms, clinical features, investigations, treatments and visual outcomes were examined and recorded.Results: We reviewed 11 patients including our own two cases. There was a statistically significant seasonal difference in antistreptolysin‐O titres (ASOT), and age‐related ASOT was identified. Of the 11 patients, eight (72.7%) had anterior uveitis, two (18.2%) had intermediate uveitis and one (9.1%) had panuveitis. Their ages ranged from 5 to 56 years (mean 17 years). The majority of cases had significantly elevated ASOT; most patients were treated with topical steroids and oral antibiotics and four cases underwent adenotonsillectomy. The visual prognosis was good in most cases.Conclusions: Uveitis may be the sole presenting clinical feature, or it may occur in combination with other features of post‐streptococcal infection. Ophthalmologists should be aware of the clinical features of PSU and maintain a high level of suspicion, particularly in childhood uveitis.